BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 5926186)

  • 1. Factors influencing serum ceruloplasmin levels in normal individuals.
    Cox DW
    J Lab Clin Med; 1966 Dec; 68(6):893-904. PubMed ID: 5926186
    [No Abstract]   [Full Text] [Related]  

  • 2. [Features of the course and disorders of copper and ceruloplasmin metabolism in hepatolenticular degeneration].
    Davidenkova EF; Neĭfakh SA; Butomo IV; Mashkov BA; Lapchenkov VI
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1967; 67(7):982-90. PubMed ID: 5598796
    [No Abstract]   [Full Text] [Related]  

  • 3. [Test of stimulation of ceruloplasmin activity and copper concentration as affected by diphenylhydantoin (phenytoin, TSC) in the diagnosis of hepatolenticular degeneration].
    Pakszys W; Ligezińska B; Szymański H
    Pol Tyg Lek; 1982 Nov; 37(45):1353-7. PubMed ID: 7163091
    [No Abstract]   [Full Text] [Related]  

  • 4. [Correlation between serum values of copper, ceruloplasmin, SMAO, SDAO, in health- subjects, in pregnant women and in some pathological conditions (author's transl)].
    Bombardieri G; Rossi L; Bevilacqua E; Fabiani S; Tettamanti P
    Quad Sclavo Diagn; 1976 Jun; 12(2):131-47. PubMed ID: 828961
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Pathobiochemistry of Wilson's disease].
    Biesold D; Lössner J; Bachmann H; Zotter J
    Z Med Lab Diagn; 1982 Oct; 23(5):278-84. PubMed ID: 7180077
    [No Abstract]   [Full Text] [Related]  

  • 6. [Factors affecting the concentration of serum ceruloplasmin in Wilson-Konovalov disease].
    Mzhel'skaia TI; Ivanova-Smolenskaia IA; Korobova NV
    Vopr Med Khim; 1994; 40(6):48-53. PubMed ID: 7618303
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Hepatolenticular degeneration and pregnancy].
    Tsuzuki E; Scaff M; Roitman I; Neme B; Canelas HM
    Rev Hosp Clin Fac Med Sao Paulo; 1976; 31(1):35-8. PubMed ID: 1257671
    [No Abstract]   [Full Text] [Related]  

  • 8. [Determination of copper in serum and urine of hepatolenticular degeneration patient and their clinic meaning].
    Deng SL; Li XF; Guo XL
    Guang Pu Xue Yu Guang Pu Fen Xi; 2003 Jun; 23(3):576-8. PubMed ID: 12953546
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Wilson's disease patients with normal ceruloplasmin levels.
    Yüce A; Koçak N; Ozen H; Gürakan F
    Turk J Pediatr; 1999; 41(1):99-102. PubMed ID: 10770682
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Further investigations on ceruloplasmin in hepatolenticular degeneration and on the effect of copper on oxidase activity of ceruloplasmin.
    Wald I; Galewicz A; Górska D
    Pol Med J; 1972; 11(3):733-9. PubMed ID: 5047986
    [No Abstract]   [Full Text] [Related]  

  • 11. Wilson's disease: the importance of measuring serum caeruloplasmin non-immunologically.
    Walshe JM;
    Ann Clin Biochem; 2003 Mar; 40(Pt 2):115-21. PubMed ID: 12662398
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Fluctuating blood copper concentrations].
    Köbberling J
    Dtsch Med Wochenschr; 1995 Mar; 120(13):461-2. PubMed ID: 7712938
    [No Abstract]   [Full Text] [Related]  

  • 13. Studies on copper metabolism. XIV. Copper, ceruloplasmin and oxidase activity in sera of normal human subjects, pregnant women, and patients with infection, hepatolenticular degeneration and the nephrotic syndrome.
    MARKOWITZ H; GUBLER CJ; MAHONEY JP; CARTWRIGHT GE; WINTROBE MM
    J Clin Invest; 1955 Oct; 34(10):1498-508. PubMed ID: 13263429
    [No Abstract]   [Full Text] [Related]  

  • 14. [Ceruloplasmin in hepatolenticular degeneration and the effect of copper on oxidative activity of ceruloplasmin].
    Wald I; Galewicz A; Górska D
    Neurol Neurochir Pol; 1971; 5(5):622-9. PubMed ID: 4258660
    [No Abstract]   [Full Text] [Related]  

  • 15. A study on the concentrations of serum zinc, non-ceruloplasmin copper, reactive oxygen and nitrogen species in children with Wilson's disease.
    Geetha A; Jeyachristy SA; Selvamathy SM; Ilavarasi S; Surendran R
    Clin Chim Acta; 2007 Aug; 383(1-2):165-7. PubMed ID: 17573059
    [No Abstract]   [Full Text] [Related]  

  • 16. Serum ceruloplasmin levels in healthy persons and in certain pathologic conditions.
    Lyko J
    Acta Med Pol; 1967; 8(3):269-77. PubMed ID: 6062192
    [No Abstract]   [Full Text] [Related]  

  • 17. Is low serum tocopherol in Wilson's disease a significant symptom?
    Sinha S; Christopher R; Arunodaya GR; Prashanth LK; Gopinath G; Swamy HS; Taly AB
    J Neurol Sci; 2005 Feb; 228(2):121-3. PubMed ID: 15694191
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Plasma levels of ceruloplasmin and copper in children with hepatic damage].
    Larrain F; Urbina AM; Lorenzo C; Danus O
    Rev Chil Pediatr; 1975; 46(4):351-5. PubMed ID: 1233556
    [No Abstract]   [Full Text] [Related]  

  • 19. Changes in serum copper and serum ceruloplasmin concentration induced by surgical trauma.
    Hallböök T; Hedelin H
    Acta Chir Scand; 1980; 146(6):371-3. PubMed ID: 7468069
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum antioxidant activity in normal and abnormal subjects.
    Cranfield LM; Gollan JL; White AG; Dormandy TL
    Ann Clin Biochem; 1979 Nov; 16(6):299-306. PubMed ID: 539789
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.